Does RUCAPARIB CAMSYLATE Cause Disease progression? 8 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Disease progression have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 0.1% of all adverse event reports for RUCAPARIB CAMSYLATE.
8
Reports of Disease progression with RUCAPARIB CAMSYLATE
0.1%
of all RUCAPARIB CAMSYLATE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Disease progression From RUCAPARIB CAMSYLATE?
Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Disease progression Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE